Escitalopram Impurity
- CAS No.
- 1363421-46-8
- Chemical Name:
- Escitalopram Impurity
- Synonyms
- MOMIPP;MOMIPP, 10 mM in DMSO;Escitalopram Impurity;(E)-3-(5-Methoxy-2-methyl-1H-indol-3-yl)-1-(pyridin-4-yl)prop-2-en-1-one;(2E)-3-(5-Methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one;2-Propen-1-one, 3-(5-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-, (2E)-;inhibit,Inhibitor,JNK1/2,BBB,Fab1,c-Jun,MOMIPP,Bcl-2,PIKfyve,Macropinocytosis,Bcl-xL
- CBNumber:
- CB74808557
- Molecular Formula:
- C18H16N2O2
- Molecular Weight:
- 292.33
- MDL Number:
- MFCD34476008
- MOL File:
- 1363421-46-8.mol
- MSDS File:
- SDS
- TDS File:
- TDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 |
Escitalopram Impurity price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 39671 | MOMIPP ≥98% | 1363421-46-8 | 50mg | $42 | 2026-04-30 | Buy |
| Cayman Chemical | 39671 | MOMIPP ≥98% | 1363421-46-8 | 100mg | $80 | 2026-04-30 | Buy |
| Cayman Chemical | 39671 | MOMIPP ≥98% | 1363421-46-8 | 250mg | $147 | 2026-04-30 | Buy |
| Cayman Chemical | 39671 | MOMIPP ≥98% | 1363421-46-8 | 500mg | $272 | 2026-04-30 | Buy |
| Biosynth | NEC42146 | (2E)-3-(5-Methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propen-1-one | 1363421-46-8 | 100mg | $686 | 2026-06-04 | Buy |
Escitalopram Impurity Chemical Properties, Uses, Production
Uses
MOMIPP, a macropinocytosis inducer, is a PIKfyve inhibitor. MOMIPP penetrates the blood-brain barrier (BBB)[1][2].
in vivo
MOMIPP (80 mg/kg; i.p.; once daily; for 15 consecutive days) shows moderately effective in suppressing progression of intracerebral glioblastoma xenografts[2].
| Animal Model: | Athymic CrTac:NCR-Foxn1 mice (female, 7-8weeks)[2] |
| Dosage: | 80mg/kg |
| Administration: | i.p.; once daily; for 15 consecutive days |
| Result: | Suppressed progression of intracerebral glioblastoma xenografts. |
References
[1] Margaux Colin, et al. Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of Temozolomide. Cancers (Basel). 2019 Mar 22;11(3):411. DOI:10.3390/cancers11030411
[2] Zehui Li, et al. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma. BMC Cancer. 2019 Jan 16;19(1):77. DOI:10.1186/s12885-019-5288-y
Escitalopram Impurity Preparation Products And Raw materials
Raw materials
Preparation Products
Escitalopram Impurity Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| MQ (shanghai) Pharmaceuticals Co., Ltd. | 13761635123 | sales@linyuepharm.com | China | 5731 | 55 |
| Angel Pharmatech, Ltd. | 17317130613 | 3358272972@qq.com | China | 3307 | 58 |
| Chengdu Gelingsu Biotechnology Co., Ltd. | 18508196360 1355086427 | hongsong0209@163.com | China | 86 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| ShangHai ChuanQian Chemcial Technique Centre | 15869524721 | 3525679403@qq.com | China | 4565 | 58 |
| Zhejiang Huida Biotech Co., LTD | 0571-89903022 18679456698 | zilong@hizyme.com | China | 8001 | 58 |
| Jinan Jiuli Biotechnology Co. , Ltd. | 15865264761 | 486064515@qq.com | China | 5000 | 58 |
| Nantong Hi-Future Biotechnology Co., Ltd | +86-0513; 18051384581 | sales@chemhifuture.com | China | 3075 | 58 |
| Hefei Mokai Pharmaceutical Technology Co., Ltd | 18130062233 | 690231469@qq.com | China | 8000 | 58 |
1363421-46-8 (Escitalopram Impurity) Related Search:
1of3






